|
Catalog Number 93899 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Erythema (1840); Vascular System (Circulation), Impaired (2572)
|
Event Date 11/29/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The events of redness and vascular event are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.This is a known potential adverse event addressed in the product labeling.A review of the device history record has been initiated.If any deviations or non-conformances are found, a supplemental medwatch will be submitted.
|
|
Event Description
|
Healthcare professional reported after injection in the "glabella and pre jowl focus" with one syringe juvéderm® ultra xc, the patient experienced ¿redness that was found to be a vascular event¿ noticed two days after injection.6 days after injection, the patient was injected with hylenex as treatment; 3 days later, nitrobid paste was given as treatment.Symptoms are ongoing.
|
|
Search Alerts/Recalls
|
|
|